Expression of intermediate filaments in ovarian and uterine tumors.
We studied the expression of cytoskeletal intermediate filaments in different types of ovarian and uterine sarcomas and carcinomas. In both uterine and ovarian leiomyosarcomas, in endometrial stromal sarcomas, and also in ovarian sarcomas, most tumor cells appeared to be positive for desmin, the muscle type of intermediate filament protein. In most of the tumors, vimentin was present only in some neoplastic cells and in the vascular endothelia. Interestingly, both uterine and ovarian malignant mixed mesodermal tumors appeared to express several types of intermediate filaments, most of the stromal cells being positive for vimentin or desmin, and the epithelial component expressing keratin. The results show that most of the sarcomatous tumors of the ovary and uterus express mainly muscle type of intermediate filament protein. The results also demonstrate the ability of cells of mesodermal origin to express epithelial cytoskeleton markers--cytokeratins.
D000230:Adenocarcinoma / Q000378:metabolism; D003536:Cystadenocarcinoma / Q000378:metabolism; D003893:Desmin; D005260:Female; D006651:Histocytochemistry; D006801:Humans; D007381:Intermediate Filament Proteins / Q000378:metabolism*; D007633:Keratins / Q000378:metabolism; D007890:Leiomyosarcoma / Q000378:metabolism; D009373:Neoplasms, Germ Cell and Embryonal / Q000378:metabolism; D010051:Ovarian Neoplasms / Q000378:metabolism*; D012509:Sarcoma / Q000378:metabolism; D014594:Uterine Neoplasms / Q000378:metabolism*; D014746:Vimentin
D003893:Desmin; D007381:Intermediate Filament Proteins; D014746:Vimentin; D007633:Keratins